[Evaluation of safety and immunogenicity of the Td vaccine in laboratory studies].
The new vaccine recommended as the booster dose contains in 0.5 ml: 10 BU Te-toxoid, 2 Lf Di-toxoid, 4.5-0.5 mg Al and 0.01% merthiolate. In 7 consecutive series it was state, the vaccine was safety and stable. The potency was 40-50 JO for Te and 30-40 for Di. The last series was recommended for vaccination under clinical control.
Rymkiewicz
D
D
Zakład Badania Surowic i Szczepionek Państwowego Zakładu Higieny, Warszawie.
Sawicki
J
J
Wysokińska
T
T
D004168:Diphtheria Toxoid / Q000008:administration & dosage*; D006801:Humans; D013745:Tetanus Toxoid / Q000008:administration & dosage*
D004168:Diphtheria Toxoid; D013745:Tetanus Toxoid
Ocena bezpieczeństwa i immunogenności szczepionki Td w badaniach laboratoryjnych.